BTAI
#4531
BioXcel Therapeutics, Inc. - Common Stock
0.7 2 USD
-0.08%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-7.69%
Monthly Change
-14.29%
6 month change
-56.36%
Year Change
-54.43%
Previous Close
0.7 8
Open
0.7 2
Low
0.7 2
High
0.7 2
Volume
4
Financials
- Market Capitalization 22.54 M
- Employee 29
- Founded 2017
- CEO N/A
- Website www.bioxceltherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG00K20GVD2
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-0.28
Price to sales ratio
30.42
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4521 |  JSPR Jasper Therapeutics, Inc. - Class A Common Stock | 0.70 USD | -2.78% | +2.94% | +11.11% | -75.35% | 23.29 M USD | ||
| 4523 |  GNTA Genenta Science S.p.A. - American Depositary Shares | 0.99 USD | -12.39% | -18.85% | -37.34% | -73.74% | 23.20 M USD | ||
| 4536 |  LGVN Longeveron Inc. - Class A Common stock | 6.80 USD | +871.43% | +690.70% | +1014.75% | +1090.27% | 21.68 M USD | ||
| 4540 |  COCP Cocrystal Pharma, Inc. - Common Stock | 1.14 USD | +1.79% | -4.20% | +22.58% | -26.92% | 21.96 M USD |
Frequently asked questions about BioXcel Therapeutics, Inc. Common Stock
What is the BioXcel Therapeutics, Inc. Common Stock stock price today?
The current price of BioXcel Therapeutics, Inc. Common Stock (BTAI) is 0.72. Over the past 24 hours, the stock has changed by -7.69%. Follow the BTAI chart for real-time price dynamics.
What is the stock ticker of BioXcel Therapeutics, Inc. Common Stock?
BioXcel Therapeutics, Inc. Common Stock trades under the ticker BTAI. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is BioXcel Therapeutics, Inc. Common Stock stock going up?
BTAI has changed by -11.11% over the last week, -14.29% over the last month, and -54.43% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of BioXcel Therapeutics, Inc. Common Stock?
BioXcel Therapeutics, Inc. Common Stock currently has a market capitalization of 22.54 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were BioXcel Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, BioXcel Therapeutics, Inc. Common Stock reported earnings of -0.49 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was BioXcel Therapeutics, Inc. Common Stock revenue for the last quarter?
BioXcel Therapeutics, Inc. Common Stock reported quarterly revenue of 182 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was BioXcel Therapeutics, Inc. Common Stock net income for the last quarter?
BioXcel Therapeutics, Inc. Common Stock reported net income of -14.71 M for the last quarter. The previous quarter showed -12.69 M, which means net income changed by -15.93%.
How many employees does BioXcel Therapeutics, Inc. Common Stock have?
As of the latest available data, BioXcel Therapeutics, Inc. Common Stock has 29 employees. Workforce size can provide additional context about the company's scale and operations.
What is BioXcel Therapeutics, Inc. Common Stock EBITDA?
BioXcel Therapeutics, Inc. Common Stock EBITDA is -9.4 M, and its EBITDA margin is -5 165.38%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy BioXcel Therapeutics, Inc. Common Stock stock?
You can buy BioXcel Therapeutics, Inc. Common Stock (BTAI) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in BioXcel Therapeutics, Inc. Common Stock stock?
Investing in BioXcel Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the BTAI chart and related analysis on metatrader.com as part of your research.